Calamos Advisors’s Envoy Medical Warrant COCHW Stock Holding History

Calamos Advisors’s Portfolio COCHW Stock Details COCHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.5K	Hold	100,000	–	–	﹤0.01%	968
2026 Q1	$6.64K	Hold	100,000	–	–	﹤0.01%	1179
2025 Q4	$4.33K	Hold	100,000	–	–	﹤0.01%	908
2025 Q3	$3.76K	Hold	100,000	–	–	﹤0.01%	903
2025 Q2	$4.85K	Hold	100,000	–	–	﹤0.01%	898
2025 Q1	$3.3K	Hold	100,000	–	–	﹤0.01%	883
2024 Q4	$4.87K	Hold	100,000	–	–	﹤0.01%	881
2024 Q3	$7.95K	Hold	100,000	–	–	﹤0.01%	891
2024 Q2	$5.9K	Hold	100,000	–	–	﹤0.01%	902
2024 Q1	$10.5K	Hold	100,000	–	–	﹤0.01%	892
2023 Q4	$2K	Hold	100,000	–	–	﹤0.01%	900
2023 Q3	$8.5K	Hold	100,000	–	–	﹤0.01%	878
2023 Q2	$4.58K	Hold	100,000	–	–	﹤0.01%	966
2023 Q1	$3.52K	Hold	100,000	–	–	﹤0.01%	1113
2022 Q4	$3.8K	Buy	+100,000	New	+$4.74K	﹤0.01%	1163

Other funds holding COCHW

DCM

Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

AWM

AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return

LIM

Longfellow Investment Management Boston, Massachusetts $489M AUM 9.58% 1-Year Est. Return

Calamos Advisors's COCHW Position: Q2 2026 in Review

Calamos Advisors held its Envoy Medical Warrant (COCHW) position steady in Q2 2026 at 100,000 shares worth $4.5K. The position accounts for ﹤0.01% of the portfolio, ranked #968.

Calamos Advisors first reported a position in COCHW in Q4 2022 and has held it in 15 quarters since. The position peaked at $10.5K in Q1 2024. 4 funds tracked by Wall St. Rank hold COCHW as of Q2 2026.

Calamos Advisors held 100,000 shares of Envoy Medical Warrant worth $4.5K as of Q2 2026.
Calamos Advisors left its Envoy Medical Warrant share count unchanged in Q2 2026.
Envoy Medical Warrant made up ﹤0.01% of Calamos Advisors's portfolio in Q2 2026, its #968 holding.
Calamos Advisors first reported a position in Envoy Medical Warrant in Q4 2022 and has held it in 15 quarters since.
Calamos Advisors's Envoy Medical Warrant position peaked at $10.5K in Q1 2024.
4 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.